Targeting an Intrinsically Disordered Protein by Covalent Modification.

Area of Science:

• Biochemistry
• Drug Discovery
• Proteomics

Background:

• Intrinsically disordered proteins (IDPs) are crucial in cellular regulation and disease but are difficult therapeutic targets due to their dynamic structures.
• Current drug development approaches struggle with IDPs, yielding weak binders ineffective in cellular environments.

Purpose of the Study:

• To present a generic method for targeting IDPs through covalent modification.
• To establish a foundation for developing potent and specific inhibitors for IDPs.

Main Methods:

• Demonstrated covalent modification using a cysteine-specific approach targeting calpastatin, an IDP inhibitor of calpain.
• Developed protocols to monitor covalent modification and quantify inhibition constants (Ki) and dissociation constants (Kd).

Main Results:

• Successfully demonstrated the covalent modification of calpastatin.
• Quantified the inhibition and binding characteristics, comparing Ki and Kd values.

Conclusions:

• Covalent modification presents a viable strategy for targeting IDPs, overcoming limitations of traditional methods.
• This approach can be adapted for screening and developing drugs against other disease-related IDPs.